Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Veracyte, Inc. (VCYT)  
$19.48 0.42 (2.11%) as of 4:30 Thu 4/25


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 82,823,000
Market Cap: 1.61(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $18.92 - $29.92
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  484
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Veracyte is a genomic diagnostics company. Co. develops tests that address clinical needs in the diagnosis, prognosis and treatment of cancer and other diseases. Co. provides tests in: thyroid cancer via its Afirma Genomic Sequencing Classifier (GSC) and Xpression Atlas; prostate cancer via its Decipher Biopsy and Radical Prostatectomy Genomic Classifiers; breast cancer via its Prosigna Breast Cancer Assay; lung cancer via its Percepta GSC and Percepta Nasal Swab Test; interstitial lung diseases including idiopathic pulmonary fibrosis via its Envisia Genomic Classifier; bladder cancer via its Decipher Bladder Genomic Classifier; and colon cancer via its Immunoscore Colon Cancer Test.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 60,000
Total Buy Value $0 $0 $0 $980,094
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 20,000 20,000 104,169 535,146
Total Sell Value $460,127 $460,127 $2,968,197 $14,025,264
Total People Sold 2 2 4 8
Total Sell Transactions 2 2 12 30
End Date 2024-01-25 2023-10-24 2023-04-25 2022-04-25

   
Records found: 524
  Page 1 of 21  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Eastham Karin Director   –       •      –    2024-04-01 4 AS $21.65 $216,528 D/D (10,000) 33,125 -10%     
   Eastham Karin Director   –       •      –    2024-04-01 4 OE $13.19 $131,900 D/D 10,000 43,125     -
   Stapley Marc Chief Executive Officer   •       •      –    2024-03-15 4 D $21.10 $125,988 D/D (5,971) 329,740     -
   Stapley Marc Chief Executive Officer   •       •      –    2024-03-15 4 A $0.00 $0 D/D 11,780 335,711     -
   Chambers Rebecca Chief Financial Officer   •       –      –    2024-03-15 4 D $21.10 $46,188 D/D (2,189) 146,702     -
   Chambers Rebecca Chief Financial Officer   •       –      –    2024-03-15 4 A $0.00 $0 D/D 4,318 148,891     -
   Wygant Jonathan VP, Chief Accounting Officer   •       –      –    2024-03-06 4 A $0.00 $0 D/D 23,942 49,058     -
   Leite John Chief Commercial Officer-CLIA   •       –      –    2024-03-06 4 A $0.00 $0 D/D 49,880 85,559     -
   Mcguire Annie SVP, General Counsel   •       –      –    2024-03-06 4 A $0.00 $0 D/D 49,880 97,325     -
   Stapley Marc Chief Executive Officer   •       •      –    2024-03-06 4 A $0.00 $0 D/D 114,724 323,931     -
   Febbo Phillip G. Chief Scientific & Med Officer   •       –      –    2024-03-06 4 A $0.00 $0 D/D 39,904 93,086     -
   Chambers Rebecca Chief Financial Officer   •       –      –    2024-03-06 4 A $0.00 $0 D/D 59,856 144,573     -
   Mcguire Annie SVP, General Counsel   •       –      –    2024-03-02 4 D $24.00 $104,328 D/D (4,347) 47,445     -
   Wygant Jonathan VP, Chief Accounting Officer   •       –      –    2024-03-02 4 D $24.00 $56,088 D/D (2,337) 25,116     -
   Stapley Marc Chief Executive Officer   •       •      –    2024-03-02 4 D $24.00 $318,864 D/D (13,286) 209,207     -
   Chambers Rebecca Chief Financial Officer   •       –      –    2024-03-02 4 D $24.00 $146,688 D/D (6,112) 84,717     -
   Leite John Chief Commercial Officer-CLIA   •       –      –    2024-03-02 4 D $24.00 $72,192 D/D (3,008) 35,679     -
   Jones Evan/ Fa Director   –       •      –    2024-03-01 4 S $24.36 $243,599 D/D (10,000) 37,601 19%     
   Jones Evan/ Fa Director   –       •      –    2024-03-01 4 OE $13.19 $131,900 D/D 10,000 47,601     -
   Leite John Chief Commercial Officer-CLIA   •       –      –    2023-12-02 4 D $26.54 $14,756 D/D (556) 38,687     -
   Stapley Marc Chief Executive Officer   •       •      –    2023-12-02 4 D $26.54 $85,008 D/D (3,203) 221,882     -
   Wygant Jonathan VP, Chief Accounting Officer   •       –      –    2023-12-02 4 D $26.54 $13,456 D/D (507) 27,020     -
   Chambers Rebecca Chief Financial Officer   •       –      –    2023-12-02 4 D $26.54 $47,772 D/D (1,800) 90,829     -
   Mcguire Annie SVP, General Counsel   •       –      –    2023-12-02 4 D $26.54 $21,312 D/D (803) 51,792     -
   Febbo Phillip G. Chief Scientific & Med Officer   •       –      –    2023-10-02 4 A $0.00 $0 D/D 53,182 53,182     -
  524 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 21
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us